Literature DB >> 891036

Ferritin on the surface of lymphocytes in Hodgkin's disease patients. A possible blocking substance removed by levamisole.

C Moroz, N Lahat, M Biniaminov, B Ramot.   

Abstract

Enzymatic radioiodination of surface proteins of Hodgkin's disease peripheral blood mononuclear cells revealed the presence of a blocking protein on their surface. This protein shed into the medium after incubation with levamisole, which resulted in the unmasking of surface proteins similar to those on normal monunuclear cells. The blocking substance was identified. It reacted with anti-human spleen ferritin. It had no detectable iron and dissociated into monomeric subunits of 18,000 mol. wt. by reduction and alkylation, and therefore it is most probably apoferritin rather than ferritin.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891036      PMCID: PMC1541050     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

1.  Studies on delayed hypersensitivity in Hodgkin's disease.

Authors:  A C AISENBERG
Journal:  J Clin Invest       Date:  1962-11       Impact factor: 14.808

2.  Hodgkin's disease and immunity.

Authors:  W W SCHIER; A ROTH; G OSTROFF; M H SCHRIFT
Journal:  Am J Med       Date:  1956-01       Impact factor: 4.965

3.  Rosette-forming lymphocytes in Hodgkin's disease.

Authors:  G Cohnen; W Augener; G Brittinger; S D Douglas
Journal:  N Engl J Med       Date:  1973-10-18       Impact factor: 91.245

4.  Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease.

Authors:  J R Eltringham; H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

5.  Detection of ferritin as a circulating tumor-associated antigen in Hodgkin's disease.

Authors:  C P Bieber; M M Bieber
Journal:  Natl Cancer Inst Monogr       Date:  1973-05

6.  Letter: Lung cancer in chloromethyl methyl ether workers.

Authors:  E M Beavers
Journal:  N Engl J Med       Date:  1974-04-25       Impact factor: 91.245

7.  Impaired lymphocyte function in untreated Hodgkin's disease.

Authors:  R Levy; H S Kaplan
Journal:  N Engl J Med       Date:  1974-01-24       Impact factor: 91.245

8.  Ferritin, a Hodgkin's disease associated antigen.

Authors:  Z Eshhar; S E Order; D H Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.

Authors:  Z Fuks; S Strober; H S Kaplan
Journal:  N Engl J Med       Date:  1976-12-02       Impact factor: 91.245

10.  Ferritinaemia in leukaemia and Hodgkin's disease.

Authors:  P A Jones; F M Miller; M Worwood; A Jacobs
Journal:  Br J Cancer       Date:  1973-03       Impact factor: 7.640

View more
  11 in total

1.  Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy.

Authors:  L Sirota; B Kupfer; C Moroz
Journal:  Clin Exp Immunol       Date:  1989-08       Impact factor: 4.330

2.  Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission.

Authors:  A M Liberati; M Brugia; B S Edwards; P Bertoni; E Ballatori; A Puxeddu; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 3.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Authors:  J D Kemp
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

4.  The Reed-Sternberg cell/lymphocyte interaction: ultrastructure and characteristics of binding.

Authors:  S V Payne; D G Newell; D B Jones; D H Wright
Journal:  Am J Pathol       Date:  1980-07       Impact factor: 4.307

5.  Tissue ferritin concentration and prognosis in carcinoma of the breast.

Authors:  R E Weinstein; B H Bond; B K Silberberg; C B Vaughn; P Subbaiah; D R Pieper
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

6.  Subpopulations of human T lymphocytes. XVI. Maldistribution of T cell subsets associated with abnormal locomotion of T cells in untreated adult patients with Hodgkin's disease.

Authors:  S Gupta
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

7.  Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.

Authors:  S Gupta; G Fernandes
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

8.  Ferritin-bearing T-lymphocytes and serum ferritin in patients with breast cancer.

Authors:  K Pattanapanyasat; T G Hoy; A Jacobs; S Courtney; D J Webster
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

9.  The distribution of iron and iron binding proteins in spleen with reference to Hodgkin's disease.

Authors:  K J Britten; D B Jones; M De Sousa; D H Wright
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

Review 10.  Immunological deregulation in classic hodgkin lymphoma.

Authors:  Alessandra Romano; Calogero Vetro; Giovanni Caocci; Marianna Greco; Nunziatina Laura Parrinello; Francesco Di Raimondo; Giorgio La Nasa
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.